TrialJournal of the American Heart Association2025

Impact of Dapagliflozin on Cardiometabolic Outcomes After Acute Myocardial Infarction According to Baseline Glycemic Status and Body Mass Index: Subanalyses of the DAPA-MI Trial.

Robert F Storey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.